Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863

This publication has 28 references indexed in Scilit:

• Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413
  Journal of Clinical Oncology, 2003
• Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates
  Cancer, 2002
• PROGRESSION IN AND SURVIVAL OF PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER (T3) TREATED WITH RADICAL PROSTATECTOMY AS MONOTHERAPY
  Journal of Urology, 1998
• Système d'évaluation des effets tardifs des radiations sur les tissus normaux: l'échelle SOMA-LENT
  Cancer/Radiothérapie, 1997
• Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
  New England Journal of Medicine, 1997
• The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results
  Urology, 1997
• Urinary incontinence following external-beam radiotherapy for clinically localized prostate cancer
  Urology, 1996
• Quality assurance of the EORTC radiotherapy trial 22863 for prostatic cancer: the dummy run
  Radiotherapy and Oncology, 1995
• Natural history of prostatism: Impact of urinary symptoms on quality of life in 2115 randomly selected community men
  Urology, 1994
• Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706
  International Journal of Radiation Oncology*Biology*Physics, 1991